5-year adherence to adjuvant endocrine treatment in Dutch women with early stage breast cancer: A population-based database study (2006-2016)
CONCLUSION: Dutch 5-year AHT adherence appears to remain poor. Improving AHT adherence in HR+ breast cancer survivors is a critical medical need.PMID:37927248 | DOI:10.3233/BD-230024
Source: Breast Disease - Category: Cancer & Oncology Authors: Yannick J P G van den Biggelaar Josephina G Kuiper Maurice J C van der Sangen Ernest J T Luiten Sabine Siesling Myrthe van Herk-Sukel Adri C Voogd Ilse Mesters Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Databases & Libraries | Endocrine Therapy | Hormonal Therapy | Hormones | Netherlands Health | Statistics | Study | Tamoxifen | Women